glp-1 weight loss drugs side effects GLP-1RA Essentials in Gastroenterology: Effect Management, Precautions for Endoscopy and Applications for Gastrointestinal Disease Treatment Long-term Success of GLP-1s Hinges
Description
Patients with BMI 27 to 29.9 may qualify when conditions such as high blood pressure, prediabetes, diabetes, high cholesterol, or sleep apnea are documented
It's important to understand that these medications follow a gradual dose escalation schedule to minimize side effects, particularly nausea and gastrointestinal discomfort
Unlike 503A compounding pharmacies, which create drugs based on individual prescriptions, 503B facilities manufacturer medications in bulk as the 503B designation is designed to do
Susan Peirce Thompson, who recently was on episode 211, to discuss the very popular topic of GLP-1 class drugs for weight loss
10.1016/j.ajog.2024.08.024 Am J Obstet Gynecol
February 25, 2025
